Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Erik K. Foged"'
Publikováno v:
Dermatology. 170:195-198
In 85 patients with psoriasis vulgaris the efficacy and tolerance of domoprednate and betamethasone valerate were studied in a double-blind, randomized trial lasting 4 weeks. Complete or satisfactory remission was obtained in 36% in the domoprednate
Autor:
Erik K. Foged, Kjœr Jacobsen
Publikováno v:
Dermatology. 164:395-403
In a retrospective study clinical and hepatotoxic side effects caused by Tigason treatment are investigated. The material consists of data on 27 patients with normal liver function tests at the beginning of treatment. The clinical side effects encoun
Autor:
W. Remy, Knud Kragballe, Troels Herlin, Kjœr Jacobsen, Antonella Tosti, Kristian Thestrup-Pedersen, Tadashi Tezuka, Sarah Brenner, Erik K. Foged, Jørgen R. Jensen, Annalisa Patrizi, Claudio Varotti, G. Martinelli, A. Krakowski, Hugh Zachariae, R. Lipitz, B. Ilie, D. Grigoriu, Marco Gobbi, R. Broux, J. Demaubeuge, Dominique Tennstedt, J. Delacrétaz, Julian Verbov, Marie Cramers
Publikováno v:
Dermatology. 164:I-VI
Autor:
Erik K. Foged, Susanne Ullman, Grete Laurberg, Poul Ølholm Larsen, Per Holm, Kresten Roesdahle, Flemming Reymann
Publikováno v:
Dermatology. 166:220-223
50 patients with palmoplantar pustulosis (PPP) were randomized to 8 weeks of daily treatment with either oral etretinate, 1 mg/kg b.w. or placebo. Good or moderate effect was obtained in 18 of 20 patients on etretinate compared to 6 of 21 patients on
Autor:
Erik K. Foged, Hans-Iver Beck
Publikováno v:
Dermatology. 167:94-96
A case of toxic hepatitis caused by combination therapy with methotrexate and etretinate in the treatment of severe psoriasis is presented in a 47-year-old woman. The patient had received methotrexate alone for more than 10 years without any signs of
Autor:
Erik K. Foged
Publikováno v:
Contact Dermatitis. 11:135-136